Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05037825
What this trial is testing

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

Who this might be right for
Non-Small-Cell Lung CarcinomaMalignant MelanomaRenal Cell Carcinoma+1 more
VastBiome 800
Not applicableLooking for participantsNCT06281210
What this trial is testing

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
European Institute of Oncology 77
Large-scale testing (Phase 3)Not Yet RecruitingNCT07407517
What this trial is testing

Adjuvant Intensification for LAR

Who this might be right for
Breast Cancer FemalesTriple Negative Breast Cancer (TNBC)
Fudan University 904
Not applicableLooking for participantsNCT04959474
What this trial is testing

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage 1 Breast Cancer AJCC v8Anatomic Stage 2 Breast Cancer AJCC v8+4 more
Thomas Jefferson University 80
Testing effectiveness (Phase 2)Ended earlyNCT03435640
What this trial is testing

REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies

Who this might be right for
MelanomaMerkel Cell CarcinomaTriple Negative Breast Cancer+4 more
Nektar Therapeutics 64
Testing effectiveness (Phase 2)Study completedNCT01173497
What this trial is testing

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Who this might be right for
Estrogen Receptor Negative (ER-Negative) Breast CancerProgesterone Receptor Negative (PR-Negative) Breast CancerHuman Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer+1 more
Sanofi 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06140576
What this trial is testing

The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.

Who this might be right for
Breast Neoplasms
Zhejiang Cancer Hospital 58
Testing effectiveness (Phase 2)UnknownNCT05390476
What this trial is testing

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

Who this might be right for
Triple Negative Breast Cancer
wang shusen 126
Testing effectiveness (Phase 2)Study completedNCT05632848
What this trial is testing

Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Sun Yat-sen University 47
Large-scale testing (Phase 3)Looking for participantsNCT05999149
What this trial is testing

Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 424
Testing effectiveness (Phase 2)Study completedNCT04408118
What this trial is testing

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerTriple Negative Breast Cancer
MedSIR 100
Not applicableUnknownNCT05910710
What this trial is testing

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerNeoadjuvant ChemotherapyPembrolizumab+1 more
Samsung Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT01111825
What this trial is testing

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Puma Biotechnology, Inc. 99
Not applicableNot Yet RecruitingNCT04225858
What this trial is testing

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
The Netherlands Cancer Institute 340
Testing effectiveness (Phase 2)Ended earlyNCT04958785
What this trial is testing

Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Gilead Sciences 92
Not applicableTemporarily pausedNCT04803084
What this trial is testing

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Who this might be right for
Breast CancerTriple-negative Breast Cancer
Laura Kennedy 10
Not applicableAvailableNCT07536815
What this trial is testing

An Open-Label, Multicenter, Non-Randomized Expanded Access Protocol (EAP) Designed to Provide Leronlimab to Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer (mTNBC)

Who this might be right for
TNBCTNBC - Triple-Negative Breast CancerTNBC, Triple Negative Breast Cancer
CytoDyn, Inc.
Testing effectiveness (Phase 2)UnknownNCT00499603
What this trial is testing

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00601159
What this trial is testing

Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC

Who this might be right for
Metastatic Breast Cancer
Fudan University 70
Early research (Phase 1)Active Not RecruitingNCT03362060
What this trial is testing

PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerMetastatic Breast Cancer
Massachusetts General Hospital 20
Next Page